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INTRODUCTION
Patent ductus arteriosus is a congenital continuous
communication between the aorta and the pulmonary ar-
tery. It is normal in the foetus but it should close within
24 hours after birth. Incomplete closure can result in a
shunt of variable size and direction. It is the most com-
mon congenital vascular disease in dogs, accounting for
nearly 30% of all congenital defects (Patterson, 1968).
This defect is more often seen in females (Patterson,
1968), small breeds (Buchanan, 1994) and German
Shepherds, Cavaliers and Springer Spaniels (Van Is-
rael et al., 2002). The principal cause of PDA is site-spe-
cific hypoplasia of the smooth muscle with excessive
elastic tissue within the ductus, resulting in an incom-
plete constriction of the lumen postpartum (Buchanan,
2007). Typically, if diagnosed early, shunting is from the
systemic circulation to the pulmonary artery (left-to-
right shunt) (Moise and Short, 1987). Consequences
include overcirculation of the lungs, volume overload of
the left heart, and in some patients, left-sided congestive
heart failure. If not corrected, PDA results in a 1-year
mortality that approaches 65% (Eyster et al., 1976).
Clinical findings include exercise intolerance, cough,
breathing difficulty and decreased appetite. Diagnosis
can be confirmed by physical examination (auscultation
of the heart murmur), thoracic radiography, echocar dio-
 graphy and angiography.
Treatment of PDA involves a complete attenuation
of blood flow through the ductus. In the past, thoraco-
tomy and subsequent PDA ligation have been the pri-
mary treatment. This technique has been performed in
veterinary medicine for many years, with high success
rates and acceptable mortality rates from 8% (Eyster et
al., 1976) to 2% (Johnson, 2007). Hemorrhage is the
most important complication of SL (10% of the dogs),
being frequently fatal (79%) (Birchard et al. 1990). In
an attempt to reduce hemorrhage, sodium nitroprusside
can be administered intravenously (IV) prior to ligation
in dogs to create hypotension via the release of nitric
oxide (NO) (Hunter et al., 2003; Humm et al., 2007).
The main disadvantage of thoracotomy is its invasive
nature, although puppies in particular seem to recover
rapidly from surgery and are often discharged within
24-48 hours (Johnson, 2007).
Less invasive treatments with interventional trans-
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ABSTRACT
Patent ductus arteriosus (PDA) is one of the most common congenital vascular abnormalities in the dog.
In veterinary medicine, surgical ligation (SL) and transarterial occlusion (TO) are two possible treatments that
require general anesthesia.
Two 4-month-old dogs were anesthetized for the correction of PDA, one by SL and the other by TO. Two
different anesthetic and analgesic protocols were used, and were chosen to avoid potential complications.
This case report describes two possible anesthetic approaches for PDA corrective surgery (SL and TO).
SAMENVATTING
Persisterende ductus arteriosus (PDA) is een van de meest voorkomende congenitale hartafwijkingen bij de
hond. Chirurgische ligatie (SL) en transarteriële occlusie (TO) zijn in de diergeneeskunde twee mogelijke
behandelingen en vereisen algemene anesthesie. Bij twee honden van vier maanden oud werd onder algemene
anesthesie een PDA behandeld, één via SL en de ander via TO. Twee verschillende anesthesie- en analgesieprotocols,
gekozen om potentiële complicaties te voorkomen, werden gebruikt. Deze casereport beschrijft twee mogelijke
benaderingen voor de anesthesie van honden voor correctieve PDA-chirurgie (SL en TO).
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arterial techniques using various devices have been de-
veloped. In humans, occluders for treatment of small
diameter PDA have been used since 1992 (Cambier et
al., 1992) and their use has been the preferred treatment
for patients with suitable PDAs (Hijazi and Geggel,
1994). These techniques were developed to avoid ge-
neral anesthesia and thoracotomy and to minimize
complications and mortality (Bright, 2003). However,
general anesthesia is required in veterinary patients.
This case report describes the anesthetic manage-
ment of two 4-month-old dogs presented for correction
of PDA, one by SL and one by TO. Two different an-
esthetic and analgesic protocols were used, and were
chosen to avoid potential complications.
CASE DESCRIPTIONS
Case 1
A 15-week-old, female Jack Russell terrier weig-
hing 3.05 kg was presented to the Cardiology Service
of the Queen Mother Hospital for Animals (QMHA),
(Royal Veterinary College, London, UK) for further
examination of a previously diagnosed continuous
heart murmur.
Thoracic auscultation revealed the presence of a
grade V/VI, continuous cardiac murmur with the point
of maximum intensity over the left axillary region.
Further examination with echocardiography confir-
med the presence of a PDA with a left to right shunt.
The ostium of the ductus appeared narrow, with a dia-
meter of 1 mm. No left atrial or significant left ventri-
cular enlargement was observed. In view of the pa-
tient’s small size, transarterial occlusion of the PDA by
means of a canine Amplatz device was not considered
as a suitable option by the surgical team. It was there-
fore decided to perform a complete surgical ligation of
the PDA.
After preanesthetic examination, the patient was
classified as ASA (American Society of Anesthesiolo-
gists) IV (patient with severe systemic disease that is
a constant threat to life). Premedication included acep-
romazine (0.01 mg/kg; ACP injection, Novartis Animal
Health Ltd., UK) and pethidine (4 mg/kg; Pethidine in-
jection BP, Martindale Pharmaceuticals, UK) intra-
muscularly (IM). An IV 23 G catheter was placed in the
right cephalic vein. General anesthesia was induced
with propofol administered to effect (4 mg/kg; Vetofol
injection; Norbrook Laboratories Ltd., UK) IV 35 mi-
nutes after premedication. Following endotracheal in-
tubation using a 5.5 mm I.D. cuffed endotracheal tube
(ETT), anesthesia was maintained with isoflurane (Iso-
Flo, Abbott Laboratories UK Ltd., UK) vaporized in
oxygen, delivered via a modified T-piece. Monitoring
(S/5, Datex-Ohmeda Instrumentarium Corp., Helsinki,
Finland) included electrocardiography (ECG), pulse
oximetry, capnography, central venous pressure (CVP)
(via jugular vein), invasive arterial blood pressure
(iABP) (via dorsal pedal artery) and oesophageal body
temperature. A forced warm air device (Bair Hugger;
Arizant Healthcare, MN, USA) was used to help to
maintain body temperature. Preservative-free morphine
(0.1 mg/kg; Martindale Pharmaceuticals, UK) was ad-
ministered via the epidural route and correct positioning
of the needle was confirmed using the ’hanging drop’
technique (Naganobu and Hagio, 2007; Dugdale 2010)
with the dog placed in sternal recumbency. Carprofen
(2 mg/kg; Carprieve 5%, Norbrook Laboratories Ltd.,
UK) IV was added as part of a multi-modal analgesic
plan. During preparation for surgery, the dog breathed
spontaneously. Once inside the operating theatre, the
patient was placed in right lateral recumbency and me-
Figure 1. Heart rate (HR) in beats minute-1 and systolic (SAP), mean (MAP) and diastolic arterial pressure (DAP)
(mmHg) in case 1. Time 0 refers to surgical ligation.
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chanical intermittent positive pressure ventilation
(IPPV) was instituted to maintain normocapnia (4.66-
6.00 kPa or 35-45 mmHg) (VentiPAC, Smiths Medical
International Ltd, UK). A fentanyl (Sublimaze, Janssen-
Cilag Ltd., UK) constant rate infusion (CRI) was ad-
ministered as part of the balanced anesthetic plan at ra-
tes ranging between 0.1 and 0.2 μg/kg/minute. The SL
technique as described by Fossum (2002) was perfor-
med. Intraoperative antibiotic therapy was achieved
with IV cefuroxime (20 mg/kg; Zinacef, Glaxo-
SmithKline Ltd., UK).
Immediately after SL, slight increases in systolic
(SAP), diastolic (DAP) and mean (MAP) arterial pres-
sures were noticed (Figure 1). Heart rate (HR) increa-
sed suddenly prior to ligation and remained slightly ele-
vated for the rest of the procedure, compared to
previous values. Later, SAP, DAP and MAP remained
slightly elevated, with smaller differences between
SAP and DAP than during the anesthetic period pre-
ceding the SL. Central venous pressure values (be-
tween 3 and 5 mmHg) remained stable throughout the
procedure. A low oesophageal body temperature was
noticed throughout anesthesia (between 34.5-35ºC for
1 hour).
At the end of surgery (surgery and anesthesia lasted
65 and 165 minutes respectively), a chest drain was
placed through a small incision at the 6th intercostal
space. The chest was lavaged with warm saline and
suctioned. At the end of surgery, air (150 mL) was eva-
cuated through the chest drain to re-establish the ne-
gative pressure of the pleural cavity.
The patient was allowed to recover in the intensive
care unit. Postoperative therapy included carprofen (2
mg/kg, SID) IV, intrapleural ropivacaine (1.5 mg/kg,
SID; Naropin 7.5 mg/mL. Astra Zeneca Ltd., UK) and
methadone (0.2 mg/kg; Physeptone 10 mg/mL. Mar-
tindale Pharmaceuticals, UK) at 2, 6 and 12 hours af-
ter the end of the surgery and afterwards at 0.1 mg/kg
every 4 hours IV. Recovery was smooth and unevent-
ful. The chest drain was removed 4 hours postoperati-
vely.
The patient was sent home 4 days after surgery
with carprofen (2 mg/kg, BID) orally for the following
3 days.
Case 2
A 16-week-old, female Cocker spaniel weighing
7.6 kg was presented at the Cardiology Service of the
QMHA for further examination of a previously diag -
nosed continuous heart murmur.
Thoracic auscultation revealed a grade VI/VI con-
tinuous heart murmur with point of maximum intensity
over the left axillary region. Initial examination con-
firmed the presence of a PDA with a large volume of
left to right shunting (ductal ostium with a diameter of
3.5 - 4 mm). Echocardiography also confirmed the
presence of severe left atrial and ventricular enlarge-
ment (in line with the findings of the previous echo-
cardiogram and thoracic radiographs performed by the
referring veterinarian). Concurrent mild aortic and mo-
derate mitral regurgitation were observed. In this case,
considering the size of the ductus, transarterial occlu-
sion of the PDA by means of a canine Amplatz occlu-
sion device was chosen as the best (less invasive) tre-
atment option. There was still a possibility, because of
the small size of the patient, that the Amplatz device oc-
clusion technique would not be technically feasible and
SL would remain the only option.
Four weeks prior to the procedure, oral therapy
with an angiotensin converting enzyme (ACE) inhibi-
tor (enalapril (0.3 mg/kg, SID; Enacard, Merial, Har-
Figure 2. Heart rate (HR) in beats minute-1 and systolic (SAP), mean (MAP) and diastolic arterial pressure (DAP)
(mmHg) in case 2. Time 0 refers to occluder expansion.
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low, Essex, UK)) was begun. After preanesthetic exa-
mination, the patient was classified as ASA IV. Pre-
medication was with pethidine (4 mg/kg, IM). An IV,
23 G catheter was placed in the right cephalic vein. Ge-
neral anesthesia was induced with etomidate (0.9
mg/kg; Hypnomidate, Janssen-Cilag Ltd., UK) and
midazolam (0.3 mg/kg; Hypnovel, Roche Products
Ltd., UK) IV 45 minutes after premedication. The tra-
chea was intubated using a 7 mm I.D. cuffed ETT and
anesthesia was maintained with isoflurane vaporized in
oxygen delivered via a mini-Lack system. Monitoring
was the same as described in case 1 (with no CVP). The
patient received cefuroxime (20 mg/kg) and furose-
mide (2 mg/kg; Dimazon 5%, Intervet Ltd., UK) IV.
After transport from the preparation room to radiogra-
phy, and positioning in left lateral recumbency, IPPV
was instituted to maintain normocapnia. Fentanyl (0.1
μg/kg/minute) and lidocaine (50 μg/kg/minute; Lido-
caine Hydrochloride 2%, Hameln Pharmaceuticals
Ltd., UK) were infused IV during the procedure.
An Amplatz canine duct occluder (ACDO) (Infiniti
MedicalTM) was placed per catheter, through the fe-
moral artery, as previously described (Nguyenba and
Tobias, 2007; 2008). The procedure lasted 3 hours. Du-
ring the placement of the occluder, some ventricular
premature contractions (VPCs) were observed. In this
case, clear increases in DAP and MAP were noticed to-
gether with a small decrease in SAP (Figure 2). More-
over, a more pronounced dicrotic notch in the arterial
blood pressure waveform was observed after occlusion.
Heart rate showed a progressive decrease before oc-
clusion and increased after ligation. Body tempera-
ture was kept above 36.2ºC during the whole proce-
dure. Intraoperative radiographs showed the correct
position of the occluder (Figure 3).
Once the procedure had been completed the patient
continued to breathe 100% oxygen and received acep-
romazine (0.01 mg/kg), buprenorphine (0.02 mg/kg;
Buprecare 0.3 mg/mL, Animalcare Ltd, UK) and fu-
rosemide (1 mg/kg) IV.
The patient was sent home 3 days after the proce-
dure with benazepril (0.7 mg/kg, SID; Benazecare,
Animalcare, York, UK) and furosemide (1.3 mg/kg,
BID; Frusecare, Animalcare, York, UK) orally until
further instructions.
After the procedure, the continuous heart murmur
disappeared. A systolic murmur was still present.
DISCUSSION
Over the last decade, minimally invasive methods
have become more popular in veterinary medicine.
Transarterial occlusion using Gianturco occluders in
dogs was first performed in 1994 (Miller et al., 1999).
Coils, Amplatz vascular plugs and Amplatz duct oc-
cluders can be used in dogs (Johnson, 2007). Case re-
ports show TO to be a safe and efficacious treatment
choice in dogs with PDA (Fellows et al., 1998; Camp-
bell et al., 2006; White, 2009) with benefits including
minimal invasiveness (only a very small incision over
the femoral vessels) and decreased complication rates,
whereas disadvantages include increased procedure
time (depending on the clinician’s experience) and
decreased initial success rate (Bright, 2003). Potential
complications are pulmonary embolization of occlu-
ders (3%), arterial embolization (<5%), recanalization
of the PDA (5-20%) and hemolysis secondary to me-
chanical damage to erythrocytes (Daniels et al., 1998;
Van Israel et al., 2001; Turner et al., 2002; Galal,
2003; Saunders et al., 2004).
In case 2, an Amplatz canine duct occluder (Infiniti
MedicalTM) was used. This occluder is a self-expanding
device made from a nitinol wire mesh and is suffi-
ciently soft to be able to conform to the shape of the
PDA. These plugs are normally used to occlude me-
dium sized PDAs, of approximately 4-7 mm diameter.
After the placement of a guiding catheter, the ACDO
was introduced through the femoral artery retrogradely
into the aorta. A distal flat disk positioned on the pul-
monary arterial side of the ductal ostium provides se-
cure positioning in the pulmonary artery. As the device
is implanted, the proximal cupped disk expands to
conform to the shape of the ductal ampulla, with the
waist of the device spanning the pulmonic ostium of
the ductus and the dense nitinol mesh occluding the
communication (Nguyenba and Tobias, 2007).
In a retrospective study by Goodrich et al. (2007),
SL and TO were considered as acceptable treatments
for PDA, with similar procedure times and mortality ra-
tes.
From the perspective of anesthesia, patients for
correction of a PDA are generally young and in good
health. If the ductus is large or if PDA has not been re-
cognized early, there can be significant enlargement of
the left ventricle, which can finally result in cardiac fai-
lure due to volume overload (Pascoe, 2007).
Anesthetic management in PDA patients ideally
should be performed with drugs that prevent hemody-
namic changes. In typical PDA patients, SAP is usually
normal to high. However, DAP is usually very low be-
cause of the connection of the systemic circulation to
the low-resistance pulmonary system. Due to the low
DAP, MAP is normally in the 50-60 mmHg range.
When the ductus is ligated or occluded (which effec-
Figure 3. Intraoperative radiography to confirm the
exact positioning of the occluder.
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tively increases systemic vascular resistance), a sudden
increase in DAP with a minimal change in SAP is usu-
ally observed (Pascoe, 2007). Furthermore, the HR
decreases (Branham’s sign) in response to the increa-
sed MAP (baroreceptor response) (Hellyer, 1992). Ad-
ministration of antimuscarinic drugs (atropine or gly-
copyrrolate) can be used to counteract this sinus
bradycardia and it has been advocated as part of the
premedication protocol (Pascoe, 2007). Other authors,
however, do not recommend the use of atropine for this
reflex bradycardia (Clutton, 2007).
In the patients of the present cases, these expected
changes in blood pressure were more evident in case 2
than in case 1 (Figures 1 and 2) and hypotension did
not occur during anesthesia. Positive inotropes may be
used during the procedure to maintain SAP over 90
mmHg when necessary. Hypertension should also be
avoided as it can increase the risk of bleeding as well
as of increasing myocardial work and myocardial oxy-
gen demand, which could lead to myocardial ischemia
and cardiac arrhythmias. Furthermore, hypertension
can result in retinopathy, blindness and renal failure
(Egger, 2007). 
In case 1, HR increased suddenly prior to ligation
(probably due to cardiac manipulation) with a slight
decrease after ligation (Branham’s sign and/or reduc-
tion of surgical stimulation). After ligation and for the
rest of the procedure, HR tended to be constant, alt-
hough slightly higher than pre-ligation values. In con-
trast, in case 2 where minimal surgical stimulation
was present, HR slightly decreased prior to occlusion,
with a clear drop in HR after the ACDO occluded the
PDA.
In view of the pathophysiological cardiovascular
changes observed with a PDA, peripheral vasocon-
strictors should be avoided since an increase in SVR
tends to increase the left-to-right shunt through the
ductus and may lead to pulmonary edema (Pascoe,
2007). On the other hand, large decreases in systemic
vascular resistance (SVR) should also be avoided,
since these may cause hypotension and possibly even
shunt reversal (right-to-left shunt) if the pressure in the
pulmonary artery exceeds the pressure in the aorta.
Phenothiazines and butyrophenones are premedicants
that induce a significant reduction in SVR and should
be used with caution in PDA patients. However, in less
severe cases, modest reductions in SVR increase sys-
temic blood flow and may reduce left-to-right shunt be-
fore ligation. Therefore, in case 1, a low dose of acep-
romazine (0.01 mg/kg), which causes systemic
vasodilation, was administered IM in combination with
the short acting mu-opioid agonist, pethidine (4
mg/kg). Premedication in case 2 was achieved with pet-
hidine alone, which produces mild sedation at analge-
sic doses (3-5 mg/kg) (Kerr, 2007). 
For the induction of anesthesia, propofol IV was
used in case 1. Propofol has been shown to produce a
significant decrease in SAP in dogs premedicated with
acepromazine (Smith et al., 1993), which makes it a
less than ideal combination in the present case. In case
2, co-induction of anesthesia with etomidate (0.85
mg/kg) and midazolam (0.3 mg/kg) was used. Etomi-
date is the induction agent of choice in animals with se-
vere cardiac disease because it has been reported to
maintain arterial blood pressure during the first few mi-
nutes of anesthesia, in contrast to propofol, although it
provides a similar duration of anesthesia. A higher in-
cidence of adverse reactions during induction, as well
as rougher recoveries, have been associated with eto-
midate induction (Sams et al., 2008). Midazolam re-
duces the doses of drugs that are required to induce and
maintain anesthesia in dogs. However, it can be asso-
ciated with excitement and increased motor activity
(Stegmann and Bester, 2001). Combinations of etomi-
date with diazepam (Humm et al., 2007) and opioids
have been successfully used in high-risk patients (Käst-
ner, 2007). Retrospectively, the induction protocol cho-
sen in case 2 was a better option than in case 1.
For the maintenance of anesthesia, isoflurane va-
porized in oxygen was used in both cases. Inhalant an-
esthetics inhibit autonomic outflow (Yamamura et al.,
1983) and cause dose-related cardiorespiratory de-
pression (Steffey and Howland, 1978; Mutoh et al.,
1997). Relatively high doses of inhalant anesthetics are
necessary to inhibit the cardiovascular responses to no-
ciception (Roizen et al., 1981) and when these drugs
are used at concentrations necessary to produce surgi-
cal anesthesia, hypotension and substantial decreases
in cardiac output/tissue oxygen delivery may follow. To
avoid these negative effects, total intravenous anes-
thesia (TIVA) could be an alternative for the induction
and maintenance of anesthesia (Musk and Flaherty,
2007).
In both patients, CRIs were used as part of a ba-
lanced anesthetic plan. A fentanyl CRI (case 1) and fen-
tanyl and lidocaine CRIs (case 2) were administered.
Fentanyl CRI provides dose-dependent analgesia and
dose-dependent MAC reduction of the inhalant anes-
thetic at clinically used doses (Murphy and Hug, 1982).
Intravenous lidocaine was used to avoid the incidence
of ventricular arrhythmias when placing the occluder
(case 2), as it is primarily used in the management of
ventricular arrhythmias, particularly those induced by
myocardial infarction or cardiac surgery (Calvey and
Williams, 2001a). Furthermore, the analgesic proper-
ties of intravenously administered lidocaine have been
demonstrated in humans (Wallin et al., 1987), rats
(Woolf and Wiesenfeld-Hallin, 1985) and ponies (Mur-
rell et al., 2005) and an additional isoflurane sparing ef-
fect has been reported in dogs (Valverde et al., 2004)
with a MAC reduction of up to 43%.
In case 1, epidural morphine (0.01 mg/kg) was ad-
ministered. In dogs undergoing thoracotomy, epidural
morphine has been shown to be more effective in the
treatment of postoperative pain than when administe-
red IV (Popilskis et al., 1993), and may result in alle-
viation of pain for up to 24 hours (Jones, 2001). Fur-
thermore, intrapleural ropivacaine was administered to
produce local anesthesia. Ropivacaine has been widely
used for postoperative pain relief. It has several bene-
fits over bupivacaine, with better differentiation be-
tween sensory and motor blockade, less cardiotoxicity,
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a shorter half-life and a more rapid clearance (Calvey
and Williams, 2001b).
Peri- and postoperative furosemide (diuretic) and
postoperative benazepril (ACE inhibitor), as chronic
therapy for congestive heart failure was administered
in case 2. Stabilization and treatment of heart failure
should be carried out in more critical patients before
anesthesia (Clutton, 2007).
Efforts should be made to prevent hypothermia,
especially when SL is performed (the exposed open
thorax promotes heat loss). The prevention of hypo-
thermia and close monitoring of body temperature in
these patients are strongly recommended.
CONCLUSION
Different anesthetic techniques can be used for SL
and TO, but whichever premedication/induction pro-
tocol is used, it should preserve cardiovascular func-
tion. The invasive nature of SL via thoracotomy re-
quires careful control of pain and therefore a good
balanced anesthetic plan should include analgesia,
isoflurane-sparing effects and avoidance of ventricu-
lar arrhythmias.
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